Chapter 34: The Human Microbiome – The Microbe-Human Ecosystem
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
The collective microbial community, or microbiome, is recognized as essential for normal physiological function, supplying genes and metabolites that the human genome cannot provide. Microbial colonization begins at birth, with the community structure influenced by factors like delivery mode, diet, and environment, leading to a stable but highly individualized adult microbiota that varies significantly across specific body niches like the skin and the densely populated gastrointestinal (GI) tract. The GI tract’s unique environment supports a functional core microbiome responsible for critical functions, notably breaking down complex dietary polysaccharides (fiber) into short-chain fatty acids (SCFAs) such as butyrate, which is vital for calorie absorption, weight regulation, and intestinal cell health. Moreover, the microbiome is indispensable for developing a mature, functional immune system, a concept evidenced by studies involving germ-free mice. These microbial communities maintain colonization resistance against incoming pathogens through both direct mechanisms (like bacteriocin production) and indirect mechanisms (like modulating local oxygen tension). The microbial influence extends to the nervous system via the gut-brain axis, where bacterial products and immune signaling modulate neurological function and behavior. When the balance is disrupted, a state called dysbiosis occurs, often leading to chronic inflammation associated with major global diseases; examples include metabolic syndrome (linked to high-fat diets causing a "leaky gut" and metabolic endotoxemia from LPS leakage), cardiovascular disease (associated with TMA/TMAO production from meat-eating microbes), and various cancers fueled by chronic inflammation or specific DNA-damaging bacterial toxins. Recognizing the power of this ecosystem, therapeutic interventions are emerging, including fecal microbiome transplant (FMT) for treating severe C. difficile infections, and the development of standardized probiotics and synbiotics to safely manipulate microbial populations for preventative and therapeutic health benefits.